천식 치료 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 약물 종류별, 투여 방법별, 유통 채널별, 지역별, 경쟁별(2020-2030년)
Asthma Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class, By Mode of Administration, By Distribution Channel, By Region and Competition, 2020-2030F
상품코드:1719126
리서치사:TechSci Research
발행일:2025년 04월
페이지 정보:영문 186 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
천식 치료 세계 시장 규모는 2024년에 278억 4,000만 달러로 예측 기간 동안 4.58%의 CAGR로 성장하여 2030년에는 364억 7,000만 달러에 달할 것으로 예상됩니다.
천식 유병률 증가, 헬스케어 투자 증가, 첨단 치료제에 초점을 맞춘 연구 개발 이니셔티브의 확대로 시장이 확대되고 있습니다. 천식은 여전히 세계 공중보건의 큰 문제이며, 특히 미국과 같은 국가에서는 천식의 부담이 커서 효과적인 치료에 대한 큰 수요가 발생하고 있습니다. 스마트 흡입기 및 분무기와 같은 약물전달 시스템의 혁신과 생물학적 제제의 가용성 확대로 천식 관리가 크게 변화하고 있습니다. 생물학적 제제 치료는 중증 환자들을 대상으로 한 표적 중재를 통해 결과를 개선하고 입원을 줄입니다. 이러한 발전은 환자 중심의 정밀의료에 대한 관심과 함께 세계 천식 치료 시장의 지속적인 성장을 촉진할 것으로 예상됩니다.
The Global Asthma Treatment Market was valued at USD 27.84 billion in 2024 and is projected to reach USD 36.47 billion by 2030, growing at a CAGR of 4.58% during the forecast period. The market is expanding due to the rising prevalence of asthma, increased healthcare investment, and growing R&D initiatives focused on advanced therapeutics. Asthma remains a major public health concern globally, particularly in countries like the United States, where its burden has created significant demand for effective treatments. Technological innovations in drug delivery systems-such as smart inhalers and nebulizers-and the growing availability of biologic therapies are transforming asthma management. Biologic treatments offer targeted intervention for severe cases, improving outcomes and reducing hospitalizations. These advancements, along with the focus on patient-centric and precision medicine, are expected to drive continued growth in the global asthma treatment landscape.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 27.84 Billion
Market Size 2030
USD 36.47 Billion
CAGR 2025-2030
4.58%
Fastest Growing Segment
Online Pharmacies
Largest Market
North America
Key Market Drivers
Increasing Investment in Research and Development
Substantial investment in R&D is a key driver of innovation in the asthma treatment market. With asthma being a complex, chronic condition, pharmaceutical companies and health organizations are prioritizing the development of new drugs and therapies to meet unmet needs. In the U.S., the National Institutes of Health (NIH) allocates over USD 100 million annually for asthma research, supporting advancements in diagnostics, treatment modalities, and prevention strategies. These investments contribute to breakthroughs in biologics, combination therapies, and personalized medicine approaches that enhance treatment effectiveness and patient outcomes. Furthermore, advancements in drug delivery devices and digital health solutions are improving disease monitoring and self-management.
Key Market Challenges
High Cost of Advanced Therapies
A major barrier in the global asthma treatment market is the high cost of biologic therapies used to treat severe asthma. These treatments, such as monoclonal antibodies, can cost thousands of dollars annually per patient, limiting access in low- and middle-income countries and placing strain on healthcare budgets even in developed regions. Limited insurance coverage and inconsistent reimbursement policies further exacerbate this issue, often resulting in delays or non-adherence to prescribed therapies. While biologics are effective, the associated costs can hinder widespread adoption, and addressing this financial barrier will be crucial for equitable access to advanced asthma treatments.
Key Market Trends
Integration of Digital Health Technologies
The increasing integration of digital technologies is reshaping asthma management. Tools such as mobile apps, wearable devices, and smart inhalers are enabling patients to track symptoms, monitor environmental triggers, and ensure medication adherence in real time. Smart inhalers equipped with sensors send usage data to connected devices, allowing both patients and healthcare providers to assess therapy effectiveness and make timely adjustments. These innovations support personalized asthma management, reduce flare-ups, and decrease hospital visits. As healthcare moves toward remote monitoring and data-driven decision-making, digital health technologies are expected to play a central role in asthma care delivery.
Key Market Players
GlaxoSmithKline, Plc
AstraZeneca Plc
Teva Pharmaceutical Industries Ltd.
Boehringer Ingelheim GmbH
Merck & Co. Inc.
Novartis AG
Sanofi SA
Roche Holding AG
Regeneron Pharmaceutical Inc.
Pfizer Inc.
Report Scope:
In this report, the Global Asthma Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Asthma Treatment Market, By Drug Class:
Short-Acting Beta-Agonists (SABA)
Long-Acting Beta-Agonists (LABA)
Inhaled Corticosteroids (ICS)
Leukotriene Modifiers
Immunomodulators
Combination Drugs
Others
Asthma Treatment Market, By Mode of Administration:
Inhalers
Nebulizers
Oral Medications
Asthma Treatment Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Asthma Treatment Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Asthma Treatment Market.
Available Customizations:
Global Asthma Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. Voice of Customer
5. Global Asthma Treatment Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Drug Class (Short-Acting Beta-Agonists (SABA), Long-Acting Beta-Agonists (LABA), Inhaled Corticosteroids (ICS), Leukotriene Modifiers, Immunomodulators, Combination Drugs, Others)
5.2.2. By Mode of Administration (Inhalers, Nebulizers, Oral Medications)
5.2.3. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others)
5.2.4. By Company (2024)
5.2.5. By Region
5.3. Market Map
6. North America Asthma Treatment Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Drug Class
6.2.2. By Mode of Administration
6.2.3. By Distribution Channel
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Asthma Treatment Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Drug Class
6.3.1.2.2. By Mode of Administration
6.3.1.2.3. By Distribution Channel
6.3.2. Mexico Asthma Treatment Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Drug Class
6.3.2.2.2. By Mode of Administration
6.3.2.2.3. By Distribution Channel
6.3.3. Canada Asthma Treatment Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Drug Class
6.3.3.2.2. By Mode of Administration
6.3.3.2.3. By Distribution Channel
7. Europe Asthma Treatment Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Drug Class
7.2.2. By Mode of Administration
7.2.3. By Distribution Channel
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France Asthma Treatment Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Drug Class
7.3.1.2.2. By Mode of Administration
7.3.1.2.3. By Distribution Channel
7.3.2. Germany Asthma Treatment Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Drug Class
7.3.2.2.2. By Mode of Administration
7.3.2.2.3. By Distribution Channel
7.3.3. United Kingdom Asthma Treatment Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Drug Class
7.3.3.2.2. By Mode of Administration
7.3.3.2.3. By Distribution Channel
7.3.4. Italy Asthma Treatment Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Drug Class
7.3.4.2.2. By Mode of Administration
7.3.4.2.3. By Distribution Channel
7.3.5. Spain Asthma Treatment Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Drug Class
7.3.5.2.2. By Mode of Administration
7.3.5.2.3. By Distribution Channel
8. Asia-Pacific Asthma Treatment Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Drug Class
8.2.2. By Mode of Administration
8.2.3. By Distribution Channel
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Asthma Treatment Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Drug Class
8.3.1.2.2. By Mode of Administration
8.3.1.2.3. By Distribution Channel
8.3.2. India Asthma Treatment Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Drug Class
8.3.2.2.2. By Mode of Administration
8.3.2.2.3. By Distribution Channel
8.3.3. South Korea Asthma Treatment Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Drug Class
8.3.3.2.2. By Mode of Administration
8.3.3.2.3. By Distribution Channel
8.3.4. Japan Asthma Treatment Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Drug Class
8.3.4.2.2. By Mode of Administration
8.3.4.2.3. By Distribution Channel
8.3.5. Australia Asthma Treatment Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Drug Class
8.3.5.2.2. By Mode of Administration
8.3.5.2.3. By Distribution Channel
9. South America Asthma Treatment Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Drug Class
9.2.2. By Mode of Administration
9.2.3. By Distribution Channel
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Asthma Treatment Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Drug Class
9.3.1.2.2. By Mode of Administration
9.3.1.2.3. By Distribution Channel
9.3.2. Argentina Asthma Treatment Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Drug Class
9.3.2.2.2. By Mode of Administration
9.3.2.2.3. By Distribution Channel
9.3.3. Colombia Asthma Treatment Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Drug Class
9.3.3.2.2. By Mode of Administration
9.3.3.2.3. By Distribution Channel
10. Middle East and Africa Asthma Treatment Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Drug Class
10.2.2. By Mode of Administration
10.2.3. By Distribution Channel
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Asthma Treatment Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Drug Class
10.3.1.2.2. By Mode of Administration
10.3.1.2.3. By Distribution Channel
10.3.2. Saudi Arabia Asthma Treatment Market Outlook
